Caissa Capital Management ltd., 10% Owner at Avalo Therapeutics, Inc. (AVTX), bought 25,000 shares at $2.96 ($74K) on 2023-04-17, disclosed to the SEC on 2023-04-18.
Open-market purchase of $74k AVTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.96 | 15,000 | $44K | 60.2% |
| 2 | $2.94 | 10,000 | $29K | 39.8% |
| Total | $2.95 avg | 25,000 | $74K | 100% |
| Filing → |
| AVTX | BUY | 2023-06-14 | $64K | — | Filing → |
| AVTX | BUY | 2023-06-09 | $56K | — | Filing → |
| AVTX | BUY | 2023-06-02 | $2K | — | Filing → |